Key Highlights
- ARK Invest acquired 39,691 shares of Tesla valued at $14.3M on April 6, 2026, distributed across three exchange-traded funds
- Tesla’s stock price declined more than 2% to $352.82 following disappointing first-quarter delivery figures
- ARK divested 25,240 Teradyne shares for $7.8M, marking the third consecutive session of selling
- Wedbush’s Dan Ives maintained his Buy recommendation with a $600 target price for Tesla
- JPMorgan analyst Ryan Brinkman upheld his Sell rating, setting a price target of $145
Cathie Wood’s investment firm ARK Invest executed notable portfolio adjustments on Monday, April 6, 2026, accumulating shares in Tesla while reducing its exposure to semiconductor equipment manufacturer Teradyne.
Tesla’s stock experienced a decline exceeding 2% during Monday’s session, settling at $352.82. The pullback followed the electric vehicle manufacturer’s release of first-quarter delivery numbers that fell short of market expectations.
Wood’s firm purchased 39,691 shares of Tesla distributed among three of its ETFs — ARK Innovation, ARK Autonomous Technology & Robotics, and ARK Space Exploration & Innovation. The combined acquisition totaled approximately $14.3 million.
This transaction represents a continuation of ARK’s strategy. The investment firm has been consistently expanding its Tesla holdings, capitalizing on recent share price declines as entry points.
Concurrently, ARK liquidated 25,240 shares of Teradyne valued at $7.8 million from its ARKK and ARKQ portfolios. This sale follows previous divestments on March 30 and March 31, suggesting a strategic withdrawal from the position.
Analyst Community Shows Sharp Divide on Tesla’s Outlook
Wood’s bullish stance on Tesla isn’t universally endorsed across the analyst community.
Dan Ives from Wedbush, recognized as a five-star analyst, reaffirmed his Buy recommendation and maintained his $600 price objective following the delivery disclosure. He acknowledged the underwhelming numbers but noted that subdued demand had already been factored into most analyst projections.
Conversely, JPMorgan’s Ryan Brinkman maintained a contrarian perspective. He preserved his Sell recommendation with a $145 price objective, characterizing Tesla’s performance as having “collapsed” across critical performance indicators.
The substantial divergence between these two forecasts — $145 compared to $600 — illustrates the profound disagreement on Wall Street regarding Tesla’s trajectory.
Based on tracking data from 32 analysts over the past three months, Tesla carries a consensus Hold rating. The breakdown consists of 13 Buy ratings, 11 Hold ratings, and 8 Sell ratings.
The mean price objective stands at $393.97, suggesting approximately 11.66% potential appreciation from Monday’s closing price.
Additional ARK Portfolio Activity from April 6
ARK also liquidated 29,773 shares of BWX Technologies, generating $6.4 million, and divested 8,484 Cameco shares for $955,043.
The investment firm additionally sold 92,758 shares of Strata Critical Medical, yielding roughly $384,945. This selling activity has persisted since the previous week.
On the acquisition front, ARK purchased 4,394 shares of Kodiak AI via its ARKQ ETF, totaling $32,603. ARK has been progressively building its Kodiak AI stake since March 30.
Current Market Positioning
As of April 6’s close, Tesla shares finished at $352.82, with the analyst consensus price target of $393.97 indicating moderate upside potential from present valuation levels.


